Context Therapeutics Inc.

Healthcare

NASDAQ:CNTX · NASDAQ Capital Market

Market Cap $58.06M Beta 1.61 P/E (TTM) -1.5

$0.63 +2.93%

+$0.02 today

52W Low $0.56High $3.62

Vol 3.05M · Avg 1.16M

EPS (TTM) -$0.42Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+12.16%

Period High

$3.36

Period Low

$0.56

Latest

$0.63

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$312.08M

MacroGenics, Inc.

NASDAQ:MGNX

$260.93M

Shattuck Labs, Inc.

NASDAQ:STTK

$235.20M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$213.63M

Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

$156.63M

InflaRx N.V.

NASDAQ:IFRX

$131.83M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$126.40M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$88.08M

ImageneBio Inc

NASDAQ:IMA

$67.67M

Clene Inc.

NASDAQ:CLNN

$61.95M

What is the latest CNTX filing?

The latest filing shown is 8-K dated Jun 15, 2026.

How many recent filings does CNTX have?

Intrinsic Alpha currently shows 20 recent filings for CNTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.